Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Share-based Compensation (2016 - 2020)

Historic Share-based Compensation for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $555000.0.

  • Forte Biosciences' Share-based Compensation rose 169032.26% to $555000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $956000.0, marking a year-over-year decrease of 5299.9%. This contributed to the annual value of $3.1 million for FY2024, which is 575.52% down from last year.
  • As of Q4 2020, Forte Biosciences' Share-based Compensation stood at $555000.0, which was up 169032.26% from $375000.0 recorded in Q3 2020.
  • Over the past 5 years, Forte Biosciences' Share-based Compensation peaked at $2.0 million during Q1 2019, and registered a low of $1000.0 during Q2 2019.
  • In the last 5 years, Forte Biosciences' Share-based Compensation had a median value of $466000.0 in 2016 and averaged $781700.0.
  • As far as peak fluctuations go, Forte Biosciences' Share-based Compensation plummeted by 9994.02% in 2019, and later surged by 1865000.0% in 2020.
  • Over the past 5 years, Forte Biosciences' Share-based Compensation (Quarter) stood at $403000.0 in 2016, then surged by 241.19% to $1.4 million in 2017, then rose by 27.27% to $1.8 million in 2018, then tumbled by 98.23% to $31000.0 in 2019, then skyrocketed by 1690.32% to $555000.0 in 2020.
  • Its Share-based Compensation was $555000.0 in Q4 2020, compared to $375000.0 in Q3 2020 and $24000.0 in Q2 2020.